Online citations, reference lists, and bibliographies.
← Back to Search

Prognostic Value Of Fat Mass And Skeletal Muscle Mass Determined By Computed Tomography In Patients Who Underwent Transcatheter Aortic Valve Implantation.

M. Mok, R. Allende, J. Leipsic, O. Altisent, María del Trigo, F. Campelo-Parada, R. Delarochelliére, É. Dumont, D. Doyle, M. Côté, Melanie R. Freeman, J. Webb, J. Rodés-Cabau
Published 2016 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Body composition (fat mass [FM] and skeletal muscle mass [SMM]) predicts clinical outcomes. In particular, loss of SMM (sarcopenia) is associated with frailty and mortality. There are no data on the prevalence and impact of FM and SMM in patients undergoing transcatheter aortic valve implantation (TAVI). The objective of this study is to determine body composition from pre-TAVI computed tomography (CT) and evaluate its association with clinical outcomes in patients who underwent TAVI. A total of 460 patients (mean age 81 ± 8 years, men: 51%) were included. Pre-TAVI CTs of the aorto-ilio-femoral axis were analyzed for FM and SMM cross-sectional area at the level of the third lumbar vertebrae (L3). Regression equations correlating cross-sectional area at L3 to total body FM and SMM were used to determine prevalence of sarcopenia, obesity, and sarcopenic obesity in patients (64%, 65%, and 46%, respectively). Most TAVI procedures were performed through a transfemoral approach (59%) using a balloon-expandable valve (94%). The 30-day and mid-term (median 12 months [interquartile range 6 to 27]) mortality rates were 6.1% and 29.6%, respectively. FM had no association with clinical outcomes, but sarcopenia predicted cumulative mortality (hazard ratio 1.55, 95% confidence interval 1.02 to 2.36, p = 0.04). In conclusion, body composition analysis from pre-TAVI CT is feasible. Sarcopenia, obesity, and sarcopenic obesity are prevalent in the TAVI population, with sarcopenia predictive of cumulative mortality.
This paper references
10.1146/ANNUREV.NUTR.17.1.527
Human body composition: advances in models and methods.
S. Heymsfield (1997)
10.1016/j.jcin.2012.06.011
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience.
P. Green (2012)
10.1139/H08-075
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.
M. Mourtzakis (2008)
10.1001/ARCHINTE.165.1.55
The obesity paradox: body mass index and outcomes in patients with heart failure.
J. Curtis (2005)
10.1016/S1470-2045(08)70153-0
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.
C. Prado (2008)
10.1016/j.jcin.2012.02.012
Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation.
S. Stortecky (2012)
10.1016/j.jamda.2011.01.003
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.
R. Fielding (2011)
10.1164/RCCM.2107031
Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.
K. Marquis (2002)
10.1016/j.clnu.2011.12.011
Body composition: why, when and for who?
R. Thibault (2012)
10.1016/j.numecd.2011.12.001
Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery.
M. Visser (2013)
10.1152/JAPPL.1997.83.1.229
Appendicular skeletal muscle mass: effects of age, gender, and ethnicity.
D. Gallagher (1997)
10.1093/OXFORDJOURNALS.AJE.A009520
Epidemiology of sarcopenia among the elderly in New Mexico.
R. Baumgartner (1998)
10.1111/J.1559-4564.2007.06673.X
The cardiometabolic syndrome and sarcopenic obesity in older persons.
L. Dominguez (2007)
European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people
A. Cruz-Jentoft (2010)
10.1093/ageing/afq034
Sarcopenia: European consensus on definition and diagnosis
A. Cruz-Jentoft (2010)
10.1161/CIRCULATIONAHA.113.007477
Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement: Results From the PARTNER (Placement of Aortic Transcatheter Valve) Trial
Suzanne V. Arnold (2014)
10.1001/ARCHINTE.160.6.861
Clinical survival predictors in patients with advanced cancer.
A. Viganò (2000)
10.1016/j.jacc.2015.05.024
Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients.
S. O’Connor (2015)
10.1038/OBY.2004.250
Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly.
R. Baumgartner (2004)
10.1038/nrcardio.2011.164
Transcatheter aortic valve implantation: current and future approaches
J. Rodés-Cabau (2012)
10.1007/BF02982705
Sarcopenia: Diagnosis and treatment
J. Morley (2008)
10.3389/fnagi.2014.00192
Sarcopenia and Physical Frailty: Two Sides of the Same Coin
M. Cesari (2014)
10.1016/j.jcin.2010.03.018
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry.
T. Lancefield (2010)
10.1152/JAPPL.2000.89.1.81
Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr.
I. Janssen (2000)
10.1016/j.cger.2011.03.003
Sarcopenia: origins and clinical relevance.
I. H. Rosenberg (2011)
10.1016/j.cjca.2012.04.015
Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement.
J. Webb (2012)
10.1136/heartjnl-2013-305314
Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score
B. Iung (2014)
10.1016/j.jamda.2011.07.004
Sarcopenia and mortality among older nursing home residents.
F. Landi (2012)
10.1016/j.jacc.2008.12.068
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.
C. Lavie (2009)
10.1016/j.jacc.2012.01.001
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement.
D. Holmes (2012)
10.1097/MCO.0b013e328312c37d
Sarcopenic obesity: definition, cause and consequences
S. Stenholm (2008)



This paper is referenced by
10.1016/j.jjcc.2019.02.010
Prognostic value of sarcopenic obesity estimated by computed tomography in patients with cardiovascular disease and undergoing surgery.
M. Yamashita (2019)
10.1016/j.cjca.2017.10.009
Prognostic Value of Psoas Muscle Area and Density in Patients Who Undergo Cardiovascular Surgery.
M. Yamashita (2017)
10.1016/j.ccl.2019.09.011
Prevalence and Prognostic Implications of Frailty in Transcatheter Aortic Valve Replacement.
P. Piankova (2020)
10.1097/RLI.0000000000000647
Fully Automated Segmentation of Connective Tissue Compartments for CT-Based Body Composition Analysis
Sebastian Nowak (2020)
10.1080/07853890.2018.1511918
Implications of low muscle mass across the continuum of care: a narrative review
C. Prado (2018)
10.1016/j.amjcard.2016.09.040
Prognostic Usefulness of Arm and Calf Circumference in Patients ≥65 Years of Age With Cardiovascular Disease.
K. Kamiya (2017)
10.1016/j.ijcard.2019.07.099
Transcatheter aortic valve replacement outcomes in mixed aortic valve disease compared to predominant aortic stenosis.
B. Heidari (2019)
Transcatheter aortic valve replacement outcomes in patients with sarcopaenia
M. Al-Hijji (2019)
10.1016/j.amjcard.2018.03.020
Usefulness of Psoas Muscle Area and Volume and Frailty Scoring to Predict Outcomes After Transcatheter Aortic Valve Implantation.
Pawel Kleczynski (2018)
10.1007/s12603-020-1448-7
Sarcopenia in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): A Systematic Review of the Literature
Dominic Bertschi (2020)
10.1016/j.jtcvs.2018.06.098
The impact of preoperative sarcopenia, defined based on psoas muscle area, on long‐term outcomes of heart valve surgery
H. Okamura (2018)
10.1308/rcsann.2017.0230
Is sarcopenia a useful predictor of outcome in patients after emergency laparotomy? A study using the NELA database
J. Trotter (2018)
10.1097/RTI.0000000000000428
Computed Tomography–based Body Composition Analysis and Its Role in Lung Cancer Care
Amelie S Troschel (2019)
10.1007/s10554-019-01582-0
Usefulness of skeletal muscle area detected by computed tomography to predict mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis study
Mohamad Soud (2019)
10.1253/circj.cj-19-1037
Hospital-Acquired Functional Decline and Clinical Outcomes in Older Patients Undergoing Transcatheter Aortic Valve Implantation.
M. Saitoh (2020)
10.1016/j.athoracsur.2018.06.024
Albumin Is Predictive of 1-Year Mortality After Transcatheter Aortic Valve Replacement.
Katherine R. Hebeler (2018)
10.1016/j.cjco.2020.09.019
Clinical Outcomes of Subcutaneous and Visceral Adipose Tissue Characteristics Assessed in Patients Underwent Transcatheter Aortic Valve Replacement
K. Shibata (2021)
10.1016/j.orcp.2019.09.005
A sex-specific evaluation of predicted lean and fat mass composition and cardiovascular disease onset and progression: A combined analysis of the ATTICA and GREECS prospective epidemiological studies.
M. Kouvari (2019)
10.1007/s12471-017-1003-2
Effect of body mass index on clinical outcome and all-cause mortality in patients undergoing transcatheter aortic valve implantation
M. Abawi (2017)
10.1016/j.ahj.2020.03.021
Sarcopenia and health-related quality of life in older adults after transcatheter aortic valve replacement.
Abdulla A Damluji (2020)
10.1016/j.acra.2017.02.008
Diagnosing Sarcopenia on Thoracic Computed Tomography: Quantitative Assessment of Skeletal Muscle Mass in Patients Undergoing Transcatheter Aortic Valve Replacement.
U. Nemec (2017)
10.3390/jcm8050712
Prognostic Impact of Low Skeletal Muscle Mass on Major Adverse Cardiovascular Events in Coronary Artery Disease: A Propensity Score-Matched Analysis of a Single Center All-Comer Cohort
D. O. Kang (2019)
10.1016/j.ahj.2016.08.016
Computed tomography-derived skeletal muscle index: A novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement.
Vishal Dahya (2016)
10.1016/j.cjca.2016.05.017
Conceptual Models of Frailty: The Sarcopenia Phenotype.
J. Afilalo (2016)
10.1002/ccd.27547
Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement
H. Hioki (2018)
10.1007/s10554-020-01776-x
Importance of combined assessment of skeletal muscle mass and density by computed tomography in predicting clinical outcomes after transcatheter aortic valve replacement
T. Tokuda (2020)
10.1016/j.amjcard.2020.10.045
Usefulness of Thoracic Aortic Calcium to Predict 1-Year Mortality after Transcatheter Aortic Valve Implantation.
Mohanad Hamandi (2020)
10.1177/1474515118822964
Effects of sarcopenia on functional improvement over the first year after cardiac surgery: a cohort study
Chiao-Hsin Teng (2019)
10.1016/j.iccl.2018.03.004
Computed Tomography Assessment for Transcatheter Aortic Valve Replacement.
M. Alkhouli (2018)
10.1111/jgs.14776
Transcatheter Aortic Valve Replacement in the Care of Older Persons with Aortic Stenosis
C. Talbot-Hamon (2017)
10.1016/j.amjcard.2020.10.039
Prognostic Value of Baseline Sarcopenia on 1-year Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation.
Yong-Hoon Yoon (2020)
10.1016/j.surge.2017.06.001
Sarcopaenia in surgical populations: A review.
Rachel S M Heard (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar